Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Earlens gets $87mm via late-stage financing

Executive Summary

Earlens Corp. (developed the first non-surgical hearing device) raised $87mm in its late-stage financing of preferred stock led by KCK, which was joined by other first-time backer Exor Seeds and returning shareholders Lightstone Ventures, CRG Partners, Windham Life Sciences Partners, Arch Healthcare, Relativity Health Fund, New Enterprise Associates, Aisling Capital, Vertex Global Healthcare, MS Pace LP, Cochlear, Mellon Foundation, Baltisches Haus, GDN Holdings, Sightline Healthcare Opportunity, and Far East Ventures. The company will use the funds for ongoing product development and the anticipated commercial rollout next year. Three representatives from KCK will join the board.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies